Exton Michael
Insider CIK 2029249 · LXRX Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2026-02-28 | 2026-03-03 | 503,263 | — | $0 | 1,006,527 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2026-02-28 | 2026-03-03 | 503,263 | — | $0 | 503,263 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2026-02-28 | 2026-03-03 | 204,831 | $1.47 | $301.1K | 298,432 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2026-02-12 | 2026-02-17 | 1,293,670 | — | $0 | 1,293,670 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2026-02-12 | 2026-02-17 | 862,440 | — | $0 | 862,440 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2025-02-13 | 2025-02-18 | 2,264,690 | — | $0 | 2,264,690 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2025-02-13 | 2025-02-18 | 1,509,790 | — | $0 | 1,509,790 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2024-07-08 | 2024-07-08 | 1,675,000 | — | $0 | 1,675,000 | SEC↗ |